PAPER Bolognin S, Cozzi B, Zambenedetti P, Zatta P
SEARCH RESULTS
330026 RESULTS
PAPER Silverstein JH
Influence of anesthetics on Alzheimer's disease: biophysical, animal model, and clinical reports.
J Alzheimers Dis. 2014;40(4):839-48. PubMed: 24577477PAPER Teipel SJ, Grothe MJ, Filippi M, Fellgiebel A, Dyrba M, Frisoni GB, Meindl T, Bokde AL, Hampel H, Klöppel S, Hauenstein K, EDSD study group
Fractional anisotropy changes in Alzheimer's disease depend on the underlying fiber tract architecture: a multiparametric DTI study using joint independent component analysis.
J Alzheimers Dis. 2014;41(1):69-83. PubMed: 24577476PAPER Siervo M, Harrison SL, Jagger C, Robinson L, Stephan BC
Metabolic syndrome and longitudinal changes in cognitive function: a systematic review and meta-analysis.
J Alzheimers Dis. 2014;41(1):151-61. PubMed: 24577475PAPER Walton JR
Chronic aluminum intake causes Alzheimer's disease: applying Sir Austin Bradford Hill's causality criteria.
J Alzheimers Dis. 2014;40(4):765-838. PubMed: 24577474PAPER Zimmermann R, Huber E, Schamber C, Lelental N, Mroczko B, Brandner S, Maler JM, Oberstein T, Szmitkowski M, Rauh M, Kornhuber J, Lewczuk P
Plasma concentrations of the amyloid-β peptides in young volunteers: the influence of the APOE genotype.
J Alzheimers Dis. 2014;40(4):1055-60. PubMed: 24577473PAPER de Oliveira J, Moreira EL, dos Santos DB, Piermartiri TC, Dutra RC, Pinton S, Tasca CI, Farina M, Prediger RD, de Bem AF
Increased susceptibility to amyloid-β-induced neurotoxicity in mice lacking the low-density lipoprotein receptor.
J Alzheimers Dis. 2014;41(1):43-60. PubMed: 24577472PAPER Haller S, Montandon ML, Rodriguez C, Moser D, Toma S, Hofmeister J, Sinanaj I, Lovblad KO, Giannakopoulos P
Acute caffeine administration effect on brain activation patterns in mild cognitive impairment.
J Alzheimers Dis. 2014;41(1):101-12. PubMed: 24577471PAPER Rábano A, Rodal I, Cuadros R, Calero M, Hernández F, Ávila J
Argyrophilic grain pathology as a natural model of tau propagation.
J Alzheimers Dis. 2014;40 Suppl 1:S123-33. PubMed: 24577470PAPER Troussière AC, Wallon D, Mouton-Liger F, Yatimi R, Robert P, Hugon J, Hannequin D, Pasquier F, Paquet C
Who needs cerebrospinal biomarkers? A national survey in clinical practice.
J Alzheimers Dis. 2014;40(4):857-61. PubMed: 24577469PAPER de Cristóbal J, García-García L, Delgado M, Pérez M, Pozo MA, Medina M
Longitudinal assessment of a transgenic animal model of tauopathy by FDG-PET imaging.
J Alzheimers Dis. 2014;40 Suppl 1:S79-89. PubMed: 24577468PAPER Gharbiya M, Trebbastoni A, Parisi F, Manganiello S, Cruciani F, D'Antonio F, De Vico U, Imbriano L, Campanelli A, De Lena C
Choroidal thinning as a new finding in Alzheimer's disease: evidence from enhanced depth imaging spectral domain optical coherence tomography.
J Alzheimers Dis. 2014;40(4):907-17. PubMed: 24577467PAPER Balasa M, Sánchez-Valle R, Antonell A, Bosch B, Olives J, Rami L, Castellví M, Molinuevo JL, Lladó A
Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment.
J Alzheimers Dis. 2014;40(4):919-27. PubMed: 24577466PAPER de Oliveira FF, Bertolucci PH, Chen ES, Smith MC
Brain-Penetrating Angiotensin-Converting Enzyme Inhibitors and Cognitive Change in Patients with Dementia due to Alzheimer's Disease.
J Alzheimers Dis. 2014 Feb 20; PubMed: 24577465PAPER Farr SA, Erickson MA, Niehoff ML, Banks WA, Morley JE
Central and peripheral administration of antisense oligonucleotide targeting amyloid-β protein precursor improves learning and memory and reduces neuroinflammatory cytokines in Tg2576 (AβPPswe) mice.
J Alzheimers Dis. 2014;40(4):1005-16. PubMed: 24577464Current Filters
No filters selected